Latest News & Information

The Centers for Medicare and Medicaid Services (CMS) notified all Medicare Part D plan sponsors that, “CMS finds any form of ‘gag clauses’ unacceptable and contrary to our efforts to promote drug price transparency and lower drug prices.”

2018 has been bursting with activity in Washington, D.C. and state legislatures related to drug pricing, opioid epidemic, PBM reforms, 340B, and Medicaid and Medicare reimbursement.

On April 11-12, hundreds of community pharmacists attended NCPA’s Congressional Pharmacy Summit, AmerisourceBergen joined pharmacy members to advocate together on Capitol Hill.

The National Community Pharmacists Association (NCPA) issued a press release on recent efforts in Kentucky and Ohio to bring transparency to the states' Medicaid managed care programs.

In a 1,000-page final 2019 Medicare Part D rule released Monday afternoon, the Centers for Medicare & Medicaid Services asserted its statutory authority to require that some portion of rebates and pharmacy DIR fees be applied at point of sale.